Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties

被引:110
作者
Taber, Katherine A. Johansen [1 ]
Dickinson, Barry D. [1 ]
机构
[1] Amer Med Assoc, Dept Sci & Biotechnol, Suite 39300,330 North Wabash Ave, Chicago, IL 60611 USA
关键词
pharmacogenomics; knowledge gap; drug response; educational resource;
D O I
10.2147/PGPM.S63715
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The use of pharmacogenomic testing in the clinical setting has the potential to improve the safety and effectiveness of drug therapy, yet studies have revealed that physicians lack knowledge about the topic of pharmacogenomics, and are not prepared to implement it in the clinical setting. This study further explores the pharmacogenomic knowledge deficit and educational resource needs among physicians. Materials and methods: Surveys of primary care physicians, cardiologists, and psychiatrists were conducted. Results: Few physicians reported familiarity with the topic of pharmacogenomics, but more reported confidence in their knowledge about the influence of genetics on drug therapy. Only a small minority had undergone formal training in pharmacogenomics, and a majority reported being unsure what type of pharmacogenomic tests were appropriate to order for the clinical situation. Respondents indicated that an ideal pharmacogenomic educational resource should be electronic and include such components as how to interpret pharmacogenomic test results, recommendations for prescribing, population subgroups most likely to be affected, and contact information for laboratories offering pharmacogenomic testing. Conclusion: Physicians continue to demonstrate pharmacogenomic knowledge gaps, and are unsure about how to use pharmacogenomic testing in clinical practice. Educational resources that are clinically oriented and easily accessible are preferred by physicians, and may best support appropriate clinical implementation of pharmacogenomics.
引用
收藏
页码:145 / 162
页数:18
相关论文
共 69 条
[1]  
American Medical Association Critical Path Institute Arizona Center for Research and Education on Therapeutics, 2008, PERS HLTH CAR REP 20
[2]  
American Medical Association Critical Path Institute Arizona Center for Research and Education on Therapeutics, 2011, PHARM INCR SAF EFF D
[3]   Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology [J].
Awada, Ahmad ;
Vandone, Anna M. ;
Aftimos, Philippe .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) :297-304
[4]   Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: A global problem [J].
Baars, MJH ;
Henneman, L ;
ten Kate, LP .
GENETICS IN MEDICINE, 2005, 7 (09) :605-610
[5]  
Bartholow M, 2013, PHARM TIMES, V79
[6]   Development and use of active clinical decision support for preemptive pharmacogenomics [J].
Bell, Gillian C. ;
Crews, Kristine R. ;
Wilkinson, Mark R. ;
Haidar, Cyrine E. ;
Hicks, J. Kevin ;
Baker, Donald K. ;
Kornegay, Nancy M. ;
Yang, Wenjian ;
Cross, Shane J. ;
Howard, Scott C. ;
Freimuth, Robert R. ;
Evans, William E. ;
Broeckel, Ulrich ;
Relling, Mary V. ;
Hoffman, James M. .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2014, 21 (E1) :E93-E99
[7]   Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine [J].
Bonter, Katherine ;
Desjardins, Clarissa ;
Currier, Nathan ;
Pun, Jason ;
Ashbury, Fredrick D. .
BMJ OPEN, 2011, 1 (01)
[8]   Delivering a Pharmacogenetic Service: Is There a Role for Genetic Counselors? [J].
Callard, Alice ;
Newman, William ;
Payne, Katherine .
JOURNAL OF GENETIC COUNSELING, 2012, 21 (04) :527-535
[9]   Pharmacogenomics and Individualized Medicine: Translating Science Into Practice [J].
Crews, K. R. ;
Hicks, J. K. ;
Pui, C-H ;
Relling, M. V. ;
Evans, W. E. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) :467-475
[10]  
Dressler Lynn G, 2013, N C Med J, V74, P509